Chiara Laezza
Institute of Endocrinology and Experimental Oncology
IEOS CNR
Via Pansini 5
80131 Naples
Italy. Electronic address:
Name/email consistency: high
- Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. Laezza, C., D'Alessandro, A., Paladino, S., Maria Malfitano, A., Chiara Proto, M., Gazzerro, P., Pisanti, S., Santoro, A., Ciaglia, E., Bifulco, M. Eur. J. Cancer (2012)
- N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. Laezza, C., Caruso, M.G., Gentile, T., Notarnicola, M., Malfitano, A.M., Di Matola, T., Messa, C., Gazzerro, P., Bifulco, M. Int. J. Cancer (2009)
- N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation. Laezza, C., Notarnicola, M., Caruso, M.G., Messa, C., Macchia, M., Bertini, S., Minutolo, F., Portella, G., Fiorentino, L., Stingo, S., Bifulco, M. FASEB J. (2006)
- Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. Laezza, C., Pisanti, S., Crescenzi, E., Bifulco, M. FEBS Lett. (2006)